BEAM
Beam Therapeutics·NASDAQ
--
--(--)
--
--(--)
BEAM fundamentals
During Q4 2025, Beam Therapeutics (BEAM) reported revenue of 114.11M, a YoY change of 279.52%. Net income was 244.30M, a YoY change of 370.38%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 0 -- | 0 -- | -- -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 763.00K +12616.67% | 51.07M +851050.00% | 8.43M +140433.33% | 16.65M +277433.33% | 15.80M +1970.64% | 20.04M -60.76% | 24.21M +187.10% | 20.12M +20.80% | 17.19M +8.82% | 316.19M +1478.04% | 7.41M -69.39% | 11.77M -41.48% | 14.27M -17.01% | 30.07M -90.49% | 7.47M +0.81% | 8.47M -28.08% | 9.70M -32.03% | 114.11M +279.52% | 139.74M -- |
Sales and Services Revenue | 0 -- | 0 -- | -- -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 6.00K -- | 763.00K +12616.67% | 51.07M +851050.00% | 8.43M +140433.33% | 16.65M +277433.33% | 15.80M +1970.64% | 20.04M -60.76% | 24.21M +187.10% | 20.12M +20.80% | 17.19M +8.82% | 316.19M +1478.04% | 7.41M -69.39% | 11.77M -41.48% | 14.27M -17.01% | 30.07M -90.49% | 7.47M +0.81% | 8.47M -28.08% | 9.70M -32.03% | 114.11M +279.52% | 139.74M -- |
Cost of Revenue | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | -- -- | -- -- | 6.00K -- | -6.00K -- | -- -- | 6.00K -- | 6.00K -- | 6.00K +200.00% | -18.00K -- | 6.00K -- | 6.00K -- | 763.00K +12616.67% | -775.00K -4205.56% | 8.43M +140433.33% | 16.65M +277433.33% | 15.80M +1970.64% | -40.88M -5175.23% | 24.21M +187.10% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 12.69M -- | 13.56M -- | 13.11M -- | 17.66M -- | 18.03M +42.10% | 26.38M +94.48% | 28.36M +116.36% | 26.29M +48.90% | 37.33M +107.03% | 40.80M +54.70% | 200.38M +606.53% | 58.98M +124.34% | 70.40M +88.60% | 114.55M +180.73% | 84.66M -57.75% | 98.62M +67.21% | 107.10M +52.14% | 109.02M -4.83% | 123.14M +45.45% | 122.26M +23.98% | 125.46M +17.14% | 183.33M +68.16% | 111.54M -9.42% | 116.67M -4.58% | 120.77M -3.74% | 130.10M -29.03% | 126.76M +13.64% | 128.62M +10.24% | 136.51M +13.03% | 131.55M +1.11% | 523.44M -- |
Selling, General and Administrative Expenses | 2.83M -- | 3.71M -- | 3.93M -- | 4.98M -- | 5.49M +93.61% | 6.16M +65.99% | 6.81M +73.38% | 6.94M +39.38% | 7.50M +36.72% | 8.35M +35.62% | 10.27M +50.81% | 13.40M +93.21% | 15.77M +110.26% | 17.77M +112.74% | 19.25M +87.36% | 24.06M +79.53% | 21.82M +38.30% | 22.68M +27.62% | 23.49M +22.04% | 24.66M +2.47% | 25.41M +16.48% | 43.26M +90.72% | 26.72M +13.77% | 29.63M +20.16% | 26.52M +4.35% | 28.66M -33.74% | 27.94M +4.55% | 26.86M -9.34% | 26.74M +0.85% | 32.28M +12.63% | 113.82M -- |
General and Administrative Expenses | 8.16M -- | 3.71M -- | -- -- | -- -- | 14.39M +76.45% | 6.16M +65.99% | -- -- | -- -- | -- -- | 29.61M +380.60% | -- -- | -- -- | -- -- | 57.22M +93.28% | -- -- | -- -- | -- -- | 87.81M +53.45% | -- -- | 24.66M -- | 25.41M -- | 43.26M -50.74% | 26.72M -- | 29.63M +20.16% | 26.52M +4.35% | 28.66M -33.74% | 27.94M +4.55% | 26.86M -9.34% | 26.74M +0.85% | 32.28M +12.63% | 113.82M -- |
Research and Development Expenses | 9.85M -- | 9.85M -- | 9.18M -- | 12.68M -- | 12.54M +27.29% | 20.22M +105.21% | 21.55M +134.76% | 19.35M +52.63% | 29.82M +137.78% | 32.45M +60.51% | 190.11M +782.20% | 45.58M +135.49% | 54.62M +83.15% | 96.78M +198.24% | 65.41M -65.59% | 74.56M +63.58% | 85.29M +56.14% | 86.34M -10.79% | 99.65M +52.34% | 97.61M +30.92% | 100.05M +17.31% | 140.08M +62.24% | 84.82M -14.88% | 87.04M -10.83% | 94.26M -5.79% | 101.44M -27.58% | 98.82M +16.50% | 101.76M +16.91% | 109.77M +16.46% | 99.28M -2.14% | 409.62M -- |
Operating Income | -12.69M -- | -13.56M -- | -13.11M -- | -17.65M -- | -18.02M -42.06% | -26.37M -94.43% | -28.36M -116.32% | -26.29M -48.92% | -37.32M -107.06% | -40.80M -54.71% | -200.37M -606.66% | -58.97M -124.36% | -69.63M -86.58% | -63.48M -55.60% | -76.22M +61.96% | -81.97M -38.99% | -91.30M -31.12% | -88.98M -40.17% | -98.93M -29.78% | -102.15M -24.62% | -108.27M -18.58% | 132.86M +249.30% | -104.13M -5.26% | -104.89M -2.69% | -106.50M +1.63% | -100.04M -175.30% | -119.29M -14.55% | -120.15M -14.54% | -126.81M -19.07% | -17.45M +82.56% | -383.69M -- |
Non-Operating Income (Loss) | -58.46M -- | -11.63M -- | -502.00K -- | -210.00K -- | -981.00K +98.32% | -1.48M +87.28% | -2.10M -318.92% | -7.93M -3677.62% | 2.87M +392.46% | -54.66M -3596.08% | -1.19M +43.56% | -17.28M -117.81% | 41.52M +1347.05% | -1.22M +97.76% | 7.01M +690.65% | 10.02M +157.97% | -15.86M -138.21% | 51.64M +4322.08% | 2.47M -64.80% | 19.37M +93.41% | 12.18M +176.78% | 11.30M -78.11% | 5.46M +121.35% | 13.88M -28.33% | 9.84M -19.24% | 9.68M -14.35% | 10.02M +83.34% | 17.86M +28.65% | 14.08M +43.18% | 261.74M +2603.11% | 303.70M -- |
Income (Loss) from Affiliates | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -25.50M -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 255.15M -- | -- -- |
Gain (Loss) on Change in Fair Value | -9.87M -- | -6.20M -- | -- -- | -- -- | -3.60M +63.54% | -1.80M +70.97% | -- -- | -- -- | -- -- | -62.88M -3393.50% | -- -- | -- -- | -- -- | 21.84M +134.72% | -- -- | -- -- | -- -- | 63.00M +188.53% | -- -- | 7.42M -- | -519.00K -- | -759.00K -101.20% | -6.39M -- | -307.00K -104.14% | -2.29M -341.43% | -1.25M -64.03% | 152.00K +102.38% | 5.53M +1902.61% | 3.18M +238.80% | -4.04M -224.82% | 4.82M -- |
Other Non-Operating Income (Loss) | -48.66M -- | -5.65M -- | -502.00K -- | -210.00K -- | 705.00K +101.45% | 7.00K +100.12% | -2.10M -318.92% | -7.93M -3677.62% | 2.87M +306.95% | 7.17M +102285.71% | -1.19M +43.56% | -17.28M -117.81% | 41.52M +1347.05% | -23.05M -421.61% | 7.01M +690.65% | 10.02M +157.97% | 9.64M -76.78% | -26.66M -15.68% | 2.47M -64.80% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -75.00K -- | -217.00K -- | -- -- | -- -- | -1.91M -2452.00% | -314.00K -44.70% | -- -- | -- -- | -- -- | -1.05M -234.71% | -- -- | -- -- | -- -- | 9.00K +100.86% | -- -- | -- -- | -- -- | -15.30M -170066.67% | -- -- | -11.95M -- | -12.70M -- | -12.06M +21.13% | -11.85M -- | -14.19M -18.71% | -12.13M +4.50% | -10.93M +9.42% | -9.86M +16.75% | -12.33M +13.14% | -10.90M +10.09% | -10.64M +2.64% | -43.73M -- |
Interest Expense | 0 -- | 0 -- | -- -- | -- -- | 68.00K -- | -68.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 75.00K -- | 217.00K -- | -- -- | -- -- | 1.98M +2542.67% | -1.98M -1013.36% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 15.30M -- | -- -- | 11.95M -- | 12.70M -- | 12.06M -21.13% | 11.85M -- | 14.19M +18.71% | 12.13M -4.50% | 10.93M -9.42% | 9.86M -16.75% | 12.33M -13.14% | 10.90M -10.09% | 10.64M -2.64% | 43.73M -- |
Pretax Income From Continuing Operations | -71.15M -- | -25.19M -- | -13.61M -- | -17.86M -- | -19.00M +73.29% | -27.85M -10.54% | -30.46M -123.79% | -34.22M -91.58% | -34.45M -81.28% | -95.46M -242.78% | -201.56M -561.76% | -76.25M -122.84% | -28.12M +18.38% | -64.71M +32.22% | -69.21M +65.66% | -71.95M +5.64% | -107.17M -281.13% | -37.35M +42.28% | -96.46M -39.36% | -82.78M -15.05% | -96.09M +10.34% | 144.16M +485.99% | -98.67M -2.29% | -91.01M -9.95% | -96.67M -0.60% | -90.35M -162.67% | -109.27M -10.74% | -102.29M -12.39% | -112.73M -16.61% | 244.30M +370.38% | -79.99M -- |
Income Tax Expense | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 2.41M -- | 1.00M -- | -- -- | -- -- | -- -- | 1.37M +36.60% | -- -- | 39.00K -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- |
Net Income | -71.15M -- | -25.19M -- | -13.61M -- | -17.86M -- | -19.00M +73.29% | -27.85M -10.54% | -30.46M -123.79% | -34.22M -91.58% | -34.45M -81.28% | -95.46M -242.78% | -201.56M -561.76% | -76.25M -122.84% | -28.12M +18.38% | -64.71M +32.22% | -69.21M +65.66% | -71.95M +5.64% | -109.58M -289.70% | -38.35M +40.73% | -96.46M -39.36% | -82.78M -15.05% | -96.09M +12.31% | 142.80M +472.36% | -98.67M -2.29% | -91.05M -10.00% | -96.67M -0.60% | -90.35M -163.27% | -109.27M -10.74% | -102.29M -12.34% | -112.73M -16.61% | 244.30M +370.38% | -79.99M -- |
Net Income Attributable to Minority Interests | -1.35M -- | 0 -- | -- -- | -- -- | 0 +100.00% | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -69.80M -- | -25.19M -- | -13.61M -- | -17.86M -- | -19.00M +72.77% | -27.85M -10.54% | -30.46M -123.79% | -34.22M -91.58% | -34.45M -81.28% | -95.46M -242.78% | -201.56M -561.76% | -76.25M -122.84% | -28.12M +18.38% | -64.71M +32.22% | -69.21M +65.66% | -71.95M +5.64% | -109.58M -289.70% | -38.35M +40.73% | -96.46M -39.36% | -82.78M -15.05% | -96.09M +12.31% | 142.80M +472.36% | -98.67M -2.29% | -91.05M -10.00% | -96.67M -0.60% | -90.35M -163.27% | -109.27M -10.74% | -102.29M -12.34% | -112.73M -16.61% | 244.30M +370.38% | -79.99M -- |
Preferred Stock Dividends | 605.00K -- | 1.11M -- | 2.96M -- | 3.23M -- | 3.26M +439.17% | 3.26M +194.23% | 1.28M -56.90% | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -70.41M -- | -26.30M -- | -16.57M -- | -21.09M -- | -22.27M +68.37% | -31.11M -18.29% | -31.73M -91.49% | -34.22M -62.27% | -34.45M -54.72% | -95.46M -206.83% | -201.56M -535.13% | -76.25M -122.84% | -28.12M +18.38% | -64.71M +32.22% | -69.21M +65.66% | -71.95M +5.64% | -109.58M -289.70% | -38.35M +40.73% | -96.46M -39.36% | -82.78M -15.05% | -96.09M +12.31% | 142.80M +472.36% | -98.67M -2.29% | -91.05M -10.00% | -96.67M -0.60% | -90.35M -163.27% | -109.27M -10.74% | -102.29M -12.34% | -112.73M -16.61% | 244.30M +370.38% | -79.99M -- |
Other Comprehensive Income | 0 -- | 0 -- | -- -- | 83.00K -- | -35.00K -- | -32.00K -- | -360.00K -- | 517.00K +522.89% | -132.00K -277.14% | -50.00K -56.25% | -15.00K +95.83% | 55.00K -89.36% | -12.00K +90.91% | -69.00K -38.00% | -2.66M -17626.67% | -1.48M -2792.73% | -484.00K -3933.33% | 2.24M +3352.17% | 1.67M +162.62% | -1.25M +15.60% | -9.00K +98.14% | 2.63M +17.11% | -1.52M -191.59% | -189.00K +84.88% | 2.87M +31977.78% | -1.08M -141.10% | -519.00K +65.97% | -150.00K +20.63% | 780.00K -72.81% | 321.00K +129.72% | 432.00K -- |
Total Comprehensive Income | -71.15M -- | -25.19M -- | -13.61M -- | -17.78M -- | -19.04M +73.24% | -27.88M -10.67% | -30.82M -126.44% | -33.70M -89.57% | -34.58M -81.64% | -95.51M -242.57% | -201.57M -554.08% | -76.20M -126.10% | -28.13M +18.66% | -64.78M +32.18% | -71.87M +64.34% | -73.43M +3.63% | -110.06M -291.25% | -36.10M +44.26% | -94.80M -31.89% | -84.03M -14.43% | -96.10M +12.69% | 145.43M +502.78% | -100.19M -5.70% | -91.24M -8.59% | -93.80M +2.39% | -91.43M -162.87% | -109.79M -9.58% | -102.44M -12.28% | -111.95M -19.35% | 244.62M +367.54% | -79.56M -- |
Total Comprehensive Income Attributable to Owners of the Company | -71.15M -- | -25.19M -- | -13.61M -- | -17.78M -- | -19.04M +73.24% | -27.88M -10.67% | -30.82M -126.44% | -33.70M -89.57% | -34.58M -81.64% | -95.51M -242.57% | -201.57M -554.08% | -76.20M -126.10% | -28.13M +18.66% | -64.78M +32.18% | -71.87M +64.34% | -73.43M +3.63% | -110.06M -291.25% | -36.10M +44.26% | -94.80M -31.89% | -84.03M -14.43% | -96.10M +12.69% | 145.43M +502.78% | -100.19M -5.70% | -91.24M -8.59% | -93.80M +2.39% | -91.43M -162.87% | -109.79M -9.58% | -102.44M -12.28% | -111.95M -19.35% | 244.62M +367.54% | -79.56M -- |
Basic EPS | -- -- | -- -- | -2.86 -- | -3.38 -- | -3.31 -- | -- -- | -1.03 +63.99% | -0.69 +79.59% | -0.69 +79.15% | -1.65 -- | -3.35 -225.24% | -1.23 -78.26% | -0.42 +39.13% | -0.95 +42.42% | -1.01 +69.85% | -1.02 +17.07% | -1.56 -271.43% | -0.54 +43.16% | -1.33 -31.68% | -1.08 -5.88% | -1.22 +21.79% | 1.75 +424.07% | -1.21 +9.02% | -1.11 -2.78% | -1.17 +4.10% | -1.08 -161.71% | -1.24 -2.48% | -1 +9.91% | -1.1 +5.98% | 2.4 +322.22% | -0.94 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.08 -- | -1.22 -- | -- -- | -1.21 -- | -1.11 -2.78% | -1.17 +4.10% | -- -- | -1.24 -2.48% | -1 +9.91% | -1.1 +5.98% | -- -- | -- -- |
Diluted EPS | -- -- | -- -- | -2.86 -- | -3.38 -- | -3.31 -- | -- -- | -1.03 +63.99% | -0.69 +79.59% | -0.69 +79.15% | -- -- | -3.35 -225.24% | -1.23 -78.26% | -0.42 +39.13% | -- -- | -1.01 +69.85% | -1.02 +17.07% | -1.56 -271.43% | -- -- | -1.33 -31.68% | -1.08 -5.88% | -1.22 +21.79% | -- -- | -1.21 +9.02% | -1.11 -2.78% | -1.17 +4.10% | -- -- | -1.24 -2.48% | -1 +9.91% | -1.1 +5.98% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.08 -- | -1.22 -- | -- -- | -1.21 -- | -1.11 -2.78% | -1.17 +4.10% | -- -- | -1.24 -2.48% | -1 +9.91% | -1.1 +5.98% | -- -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Beam Therapeutics year over year?What were the key takeaways from Beam Therapeutics’s earnings call?What is Beam Therapeutics's gross profit margin?What guidance did Beam Therapeutics's management provide for the next earnings period?Did Beam Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Beam Therapeutics's revenue and profit?What is the market's earnings forecast for Beam Therapeutics next quarter?What does Beam Therapeutics do and what are its main business segments?
